Status:
COMPLETED
Investigation on the Current Situation and Risk Factors Analysis of Exocrine Insufficiency in Chronic Pancreatitis
Lead Sponsor:
Changhai Hospital
Conditions:
Chronic Pancreatitis
Pancreatic Exocrine Insufficiency
Eligibility:
All Genders
Brief Summary
Pancreatic exocrine insufficiency (PEI) is one of the common complications of chronic pancreatitis (CP). Mild to moderate PEI may present with atypical digestive tract symptoms such as abdominal diste...
Detailed Description
Pancreatic exocrine insufficiency (PEI) is one of the common complications of chronic pancreatitis (CP). Mild to moderate PEI may present with atypical digestive tract symptoms such as abdominal diste...
Eligibility Criteria
Inclusion
- patients who underwent inpatient care at Shanghai Changhai Hospital (a WHO Collaborating Center for Pancreatology) between June 2022 and September 2024.
- patients diagnosed with chronic pancreatitis (CP)
- Voluntarily preserve feces for the detection of fecal elastase-1 (FE-1)
Exclusion
- Patients who were diagnosed with pancreatic cancer within 2 years after being diagnosed with chronic pancreatitis (CP)
- patients with groove pancreatitis,
- patients with autoimmune pancreatitis.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2024
Estimated Enrollment :
1101 Patients enrolled
Trial Details
Trial ID
NCT06946108
Start Date
June 1 2022
End Date
October 10 2024
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433